Top Stock Upgrades Today Drive Market Action Across Sectors

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  18 Sep 2025
 

•   NVO  
   
  0.00%

ACB Aurora Cannabis is making strategic moves to strengthen its European footprint with significant investments in German facility upgrades. The company's 3.81% surge to $5.18 reflects growing investor confidence in the cannabis giant's international expansion strategy. Trading volume of 1.18M shares, though below the 1.67M average, suggests measured optimism as Aurora positions itself for the evolving German cannabis market. The facility upgrades represent a crucial step in capturing market share in one of Europe's largest cannabis markets.

ALGM Allegro MicroSystems received renewed backing from Bank of America, which maintained its Buy rating despite trimming the price target. The semiconductor company's stock jumped 3.90% to $31.95 on solid volume of 1.09M shares. Allegro's position in the automotive semiconductor space continues to attract analyst attention as the electric vehicle transition accelerates. The company's magnetic sensor and power IC technologies remain critical components for next-generation automotive applications.

ANF Abercrombie & Fitch garnered significant analyst attention with BTIG initiating coverage at a Buy rating and $120 price target, representing substantial upside from Wednesday's $85.39 close. The retailer's remarkable 5.25% gain to $89.91 came on heavy volume of 1.60M shares, approaching the 2.05M average. The apparel retailer's transformation from struggling mall brand to fashion-forward powerhouse continues to impress analysts who see further runway for growth.

AVAV AeroVironment soared 4.18% to $283.43 after Bank of America initiated coverage with a Buy rating. The defense contractor's volume spiked to 1.52M shares, well above the 933.91K average, signaling strong institutional interest. AeroVironment's expertise in unmanned aircraft systems positions the company perfectly for increased defense spending and growing commercial drone applications. The company's tactical missile systems and loitering munitions represent high-growth segments within the defense portfolio.

ETSY The handmade marketplace platform gained 6.98% to $64.85 following a Relative Strength Rating upgrade, with massive volume of 6.90M shares exceeding the 5.67M average. Etsy's improved technical momentum reflects the platform's resilient marketplace model and growing seller ecosystem. The company's focus on unique, personalized goods continues to differentiate it from larger e-commerce platforms, creating sustainable competitive advantages.

FOLD Amicus Therapeutics jumped 6.40% to $8.48 after Needham upgraded the biotech from Hold to Buy with a $14 price target. The substantial volume of 5.19M shares, significantly above the 3.94M average, indicates strong institutional buying. Amicus's rare disease treatment pipeline, particularly its Fabry disease therapies, represents significant commercial potential as the company advances its gene therapy programs and expands its global footprint.

HSAI Hesai Group's sponsored ADR climbed 2.95% to $29.64 following its upgrade to Buy status, reflecting growing optimism about the LiDAR technology company's earnings prospects. Trading volume of 3.47M shares slightly exceeded the 3.30M average as investors recognized Hesai's leadership position in autonomous vehicle sensor technology. The company's partnerships with major automotive manufacturers position it well for the autonomous driving revolution.

IRMD iRadimed advanced 2.28% to $72.38 after receiving an upgrade to Zacks Rank Buy, though on lighter volume of 38.38K shares versus the 45.34K average. The medical device company's MRI-compatible patient monitoring systems serve a specialized but growing niche market. iRadimed's consistent innovation in MRI safety technology creates high barriers to entry and sustainable competitive advantages in the medical device sector.

MBLY Mobileye Global gained 2.39% to $14.59 as Deutsche Bank maintained its Buy rating, highlighting prospects for the EyeQ6 High-based SuperVision System. Heavy volume of 7.18M shares, well above the 4.30M average, reflects renewed investor interest in the autonomous driving technology leader. Intel's spinoff continues to benefit from partnerships with major automakers and its advanced driver assistance system technology.

MGNI Magnite rose modestly 0.13% to $23.88 despite receiving an upgrade to Buy, with lighter volume of 1.26M shares compared to the 3.13M average. The programmatic advertising platform's measured price action suggests investors are taking a wait-and-see approach to the connected TV advertising market. Magnite's position in the growing CTV advertising ecosystem provides leverage to secular shifts in media consumption patterns.

NKE Nike declined 0.30% to $72.10 despite RBC's upgrade to Outperform, citing the company's organizational overhaul and planned product refresh. Volume of 10.75M shares slightly exceeded the 9.86M average, indicating mixed investor sentiment. The athletic apparel giant's recent struggles have created opportunities for patient investors willing to bet on management's turnaround strategy and the enduring strength of the Nike brand.

NVAX Novavax gained 1.67% to $8.53 following a rating upgrade, though volume of 3.43M shares remained below the hefty 7.92M average. The vaccine developer's volatile trading pattern reflects ongoing uncertainty about commercial prospects for its COVID-19 and combination vaccines. Recent regulatory approvals provide some stability, but execution challenges continue to weigh on investor confidence.

NVO Novo Nordisk surged 6.40% to $61.85 after Berenberg upgraded the diabetes and obesity treatment leader amid renewed growth outlook expectations. Massive volume of 21.70M shares significantly exceeded the 16.87M average, reflecting strong institutional accumulation. The Danish pharmaceutical giant's GLP-1 diabetes and obesity medications represent one of the fastest-growing segments in healthcare, with Wegovy and Ozempic driving exceptional growth.

PLG Platinum Group Metals jumped 5.65% to $1.87 following upgrade news, with volume of 982.55K shares above the 840.32K average. The precious metals mining company benefits from growing industrial demand for platinum group metals, particularly in hydrogen fuel cell applications and traditional automotive catalysts. Supply constraints in South African mining operations continue to support favorable pricing dynamics.

SWIM Latham Group rose 1.16% to $7.84 on upgrade news related to AI-powered analysis revealing significant recovery opportunities in existing oil fields. Volume of 603.04K shares remained below the 656.72K average as investors digested the implications of enhanced recovery techniques. The swimming pool manufacturer's stock movement appears tied to broader market sentiment rather than company-specific developments.

TSLA Tesla declined 2.12% to $416.85 despite receiving a Strong Buy rating upgrade, with enormous volume of 87.72M shares slightly above the 84.72M average. The electric vehicle leader's mixed price action reflects ongoing debates about valuation and growth prospects amid increasing competition. Tesla's position in energy storage, autonomous driving, and manufacturing innovation continues to generate both enthusiasm and skepticism among analysts and investors.

USAS Americas Gold and Silver dropped 1.07% to $2.78 despite completing Phase 1 upgrades at its Galena No. 3 Shaft, with volume of 1.27M shares matching the 1.28M average. The mining company's operational improvements at its Idaho facility represent progress toward increased production capacity and operational efficiency. Precious metals miners continue to face headwinds from fluctuating commodity prices and operational challenges.

UTZ Utz Brands climbed 2.77% to $12.80 following announcements of campus upgrades at its Hanover, Pennsylvania facility. Volume of 644.48K shares remained below the 765.61K average, suggesting measured investor response to the capital investment news. The snack food manufacturer's facility improvements support its growth strategy and operational efficiency initiatives in the competitive packaged foods market.

WYNN Wynn Resorts gained 4.38% to $128.72 after Stifel raised its price target while maintaining a Buy rating, citing considerable remaining upside in the casino operator's rallying shares. Volume of 1.82M shares approached the 2.01M average as investors embraced the gaming company's recovery prospects. Wynn's premium positioning in Macau and Las Vegas markets provides leverage to improving travel and tourism trends.

Bottom line: $NVO offers the most attractive near-term opportunity with its 6.40% surge, massive institutional volume, and dominant position in the rapidly growing GLP-1 obesity and diabetes treatment market, where supply constraints continue to support pricing power and exceptional growth prospects.

View All Headlines